Product Information
FT ACID REDUCER 10 MG TABLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0947 per EA under NDC 70677110201. Its NADAC has been published 135 times since Mar 6, 2024.
FDA first approved this application on Mar 18, 2005.
Strength
10 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677110201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA075400FDA Approved
3/18/2005
On Market Since
7/19/2023
Pharmacological Classes
Price Statistics
The NADAC for FT ACID REDUCER 10 MG TABLET has been published 135 times since Mar 6, 2024, and over the history we have for it it has declined 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0947 per EA |
|---|---|
| All-time high | $0.1037 (Sep 11, 2024) |
| All-time low | $0.0874 (May 22, 2024) |
| 52-week high | $0.0992 |
| 52-week low | $0.0923 |
| Median price | $0.0959 |
| Average price | $0.0957 |
| Largest weekly change | +11.9% (Aug 21, 2024) |
| Weeks tracked | 135 |
| Tracking since | Mar 6, 2024 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ACID REDUCER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FT ACID REDUCER 10 MG TABLET, manufactured by Strategic Sourcing Services LLC, is $0.0947 per EA (NDC 70677110201), effective Sep 30, 2026.
How has the price of FT ACID REDUCER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for FT ACID REDUCER 10 MG TABLET has declined 2.6%. It has been tracked across 135 weekly CMS publications since Mar 6, 2024.
What are the highest and lowest recorded NADAC prices for FT ACID REDUCER 10 MG TABLET?
Since Mar 6, 2024, the NADAC for FT ACID REDUCER 10 MG TABLET has ranged from a low of $0.0874 (May 22, 2024) to a high of $0.1037 (Sep 11, 2024), with a median of $0.0959 per EA.
Are there cheaper alternatives to FT ACID REDUCER 10 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACID REDUCER 10 MG TABLET, is $0.0923 per EA — about 3% below FT ACID REDUCER 10 MG TABLET.
Who manufactures FT ACID REDUCER 10 MG TABLET?
FT ACID REDUCER 10 MG TABLET (NDC 70677110201) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.